A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)
Clinical trial NCT01678820 · TERMINATED
Trial details
- NCT number
- NCT01678820
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-10
- Primary completion
- 2013-11-01
- Enrollment
- 299
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.